Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Marrow Derived Stem Cells Mobilization for Treatment of Asherman's Syndrome, Atrophic Endometrium, and Recurrent Implantation Failure

NCT05343572 is registered in ClinicalTrials.gov with Hugh Taylor as lead sponsor.

NCT NCT05343572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05343572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Marrow Derived Stem Cells Mobilization for Treatment of Asherman's Syndrome, Atrophic Endometrium, and Recurrent Implantation Failure
Lead sponsor
Hugh Taylor
Phase
Phase 1
Overall status
Recruiting
Start date
November 1, 2023
Completion date
December 31, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asherman syndrome, atrophic endometrium, recurrent implantation failure